Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016, Article ID 1719720, 10 pages
http://dx.doi.org/10.1155/2016/1719720
Review Article

The Role of TLR4 on B Cell Activation and Anti-GPI Antibody Production in the Antiphospholipid Syndrome

1Department of Pediatrics, The Affiliated People’s Hospital, Jiangsu University, Zhenjiang, Jiangsu 212002, China
2Department of Laboratory Medicine, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
3Department of Clinical Laboratory and Hematology, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, China

Received 13 July 2016; Accepted 16 August 2016

Academic Editor: Kurt Blaser

Copyright © 2016 Si Cheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Zhou, D. Chen, H. Xie et al., “Activation of MAPKs in the anti- β2GPI/β2GPI-induced tissue factor expression through TLR4/IRAKs pathway in THP-1 cells,” Thrombosis Research, vol. 130, no. 4, pp. e229–e235, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. H. P. McNeil, C. N. Chesterman, and S. A. Krilis, “Immunology and clinical importance of antiphospholipid antibodies,” Advances in Immunology, vol. 49, pp. 193–280, 1991. View at Publisher · View at Google Scholar · View at Scopus
  3. H. P. McNeil, R. J. Simpson, C. N. Chesterman, and S. A. Krilis, “Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H),” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 11, pp. 4120–4124, 1990. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Cervera, M. A. Khamashta, Y. Shoenfeld et al., “Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients,” Annals of the Rheumatic Diseases, vol. 68, no. 9, pp. 1428–1432, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Zhang and K. R. McCrae, “Annexin A2 mediates endothelial cell activation by antiphospholipid/anti- β2 glycoprotein I antibodies,” Blood, vol. 105, no. 5, pp. 1964–1969, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Liu, H. Yin, M. Zhao, and Q. Lu, “TLR2 and TLR4 in autoimmune diseases: a comprehensive review,” Clinical Reviews in Allergy & Immunology, vol. 47, no. 2, pp. 136–147, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. R. A. S. Roubey, “Immunology of the antiphospholipid syndrome: antibodies, antigens, and autoimmune response,” Thrombosis and Haemostasis, vol. 82, no. 2, pp. 656–661, 1999. View at Google Scholar · View at Scopus
  8. T. Kajiwara, T. Yasuda, and E. Matsuura, “Intracellular trafficking of β2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome,” Journal of Autoimmunity, vol. 29, no. 2-3, pp. 164–173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Conti, F. R. Spinelli, C. Alessandri et al., “Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on γ2GPI-Specific T cell response,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 3, pp. 661–668, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. P. L. Meroni, “Pathogenesis of the antiphospholipid syndrome: an additional example of the mosaic of autoimmunity,” Journal of Autoimmunity, vol. 30, no. 1-2, pp. 99–103, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Xie, X. Kong, H. Zhou et al., “TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome,” Clinical Immunology, vol. 160, no. 2, pp. 198–210, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Xie, L. Sheng, H. Zhou, and J. Yan, “The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity,” British Journal of Haematology, vol. 164, no. 2, pp. 165–176, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. B. de Laat, V. Pengo, I. Pabinger et al., “The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study,” Journal of Thrombosis and Haemostasis, vol. 7, no. 11, pp. 1767–1773, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Tanimura, H. Jin, T. Suenaga et al., “β2-glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome,” Blood, vol. 125, no. 18, pp. 2835–2844, 2015. View at Publisher · View at Google Scholar
  15. B. D. Laat, M. V. Berkel, R. T. Urbanus et al., “Immune responses against domain I of β2-glycoprotein I are driven by conformational changes: domain i of β2-glycoprotein I harbors a cryptic immunogenic epitope,” Arthritis & Rheumatism, vol. 63, no. 12, pp. 3960–3968, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Jiang, N. Arase, M. Kohyama et al., “Transport of misfolded endoplasmic reticulum proteins to the cell surface by MHC class II molecules,” International Immunology, vol. 25, no. 4, pp. 235–246, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Xia, H. Zhou, L. Hu et al., “Both NF-κB and c-Jun/AP-1 involved in anti-β2GPI/β2GPI-induced tissue factor expression in monocytes,” Thrombosis and Haemostasis, vol. 109, no. 4, pp. 643–651, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Raschi, C. B. Chighizola, C. Grossi et al., “β2-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis,” Journal of Autoimmunity, vol. 55, no. 1, pp. 42–50, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. K. J. Brandt, E. K. O. Kruithof, and P. De Moerloose, “Receptors involved in cell activation by antiphospholipid antibodies,” Thrombosis Research, vol. 132, no. 4, pp. 408–413, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. E. P. Browne, “Regulation of B-cell responses by Toll-like receptors,” Immunology, vol. 136, no. 4, pp. 370–379, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Liu, C. He, H. Zhou et al., “Effects of TLR4 on β2-glycoprotein I-induced bone marrow-derived dendritic cells maturation,” Cellular Immunology, vol. 290, no. 2, pp. 226–232, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Salem, R. Subang, P. Laplante, J. S. Levine, and J. Rauch, “The dual role of innate immunity in antiphospholipid syndrome and systemic lupus erythematosus,” Lupus, vol. 23, no. 12, pp. 1327–1331, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. J. S. Levine, R. Subang, S. H. Nasr et al., “Immunization with an apoptotic cell-binding protein recapitulates the nephritis and sequential autoantibody emergence of systemic lupus erythematosus,” Journal of Immunology, vol. 177, no. 9, pp. 6504–6516, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Bao and X. Cao, “Epigenetic control of B cell development and B-cell-related immune disorders,” Clinical Reviews in Allergy & Immunology, vol. 50, no. 3, pp. 301–311, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. O. T. M. Chan, L. G. Hannum, A. M. Haberman, M. P. Madaio, and M. J. Shlomchik, “A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus,” Journal of Experimental Medicine, vol. 189, no. 10, pp. 1639–1647, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. M. J. Shlomchik, “Activating systemic autoimmunity: B's, T's, and tolls,” Current Opinion in Immunology, vol. 21, no. 6, pp. 626–633, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. F. E. Lund, “Cytokine-producing B lymphocytes—key regulators of immunity,” Current Opinion in Immunology, vol. 20, no. 3, pp. 332–338, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Bao and X. Cao, “The immune potential and immunopathology of cytokine-producing B cell subsets: a comprehensive review,” Journal of Autoimmunity, vol. 55, no. 1, pp. 10–23, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. L. C. Parker, L. R. Prince, and I. Sabroe, “Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity,” Clinical and Experimental Immunology, vol. 147, no. 2, pp. 199–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Colasanti, C. Alessandri, A. Capozzi et al., “Autoantibodies specific to a peptide of β2-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes,” Blood, vol. 120, no. 16, pp. 3360–3370, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. A. L. Defranco, D. C. Rookhuizen, and B. Hou, “Contribution of Toll-like receptor signaling to germinal center antibody responses,” Immunological Reviews, vol. 247, no. 1, pp. 64–72, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Minguet, E. P. Dopfer, C. Pollmer et al., “Enhanced B-cell activation mediated by TLR4 and BCR crosstalk,” European Journal of Immunology, vol. 38, no. 9, pp. 2475–2487, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. M. R. Dasu and I. Jialal, “Amelioration in wound healing in diabetic toll-like receptor-4 knockout mice,” Journal of Diabetes and Its Complications, vol. 27, no. 5, pp. 417–421, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Zhou, L. Sheng, H. Wang et al., “Anti-β2GPI/β2GPI stimulates activation of THP-1 cells through TLR4/MD-2/MyD88 and NF-κB signaling pathways,” Thrombosis Research, vol. 132, no. 6, pp. 742–749, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Barrio, J. Saez de Guinoa, and Y. R. Carrasco, “TLR4 signaling shapes B cell dynamics via MyD88-dependent pathways and Rac GTPases,” Journal of Immunology, vol. 191, no. 7, pp. 3867–3875, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Yanagibashi, Y. Nagai, Y. Watanabe, M. Ikutani, Y. Hirai, and K. Takatsu, “Differential requirements of MyD88 and TRIF pathways in TLR4-mediated immune responses in murine B cells,” Immunology Letters, vol. 163, no. 1, pp. 22–31, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Janssen, E. Ozcan, K. Liadaki et al., “TRIF signaling is essential for TLR4-Driven IgE class switching,” Journal of Immunology, vol. 192, no. 6, pp. 2651–2658, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Pihlgren, A. B. Silva, R. Madani et al., “TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell-independent isotype switch in mice,” Blood, vol. 121, no. 1, pp. 85–94, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Zhou, W. Li, Z. Wen et al., “Macrophages enhance tumor-derived autophagosomes (DRibbles)-induced B cells activation by TLR4/MyD88 and CD40/CD40L,” Experimental Cell Research, vol. 331, no. 2, pp. 320–330, 2015. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Cheng, C. He, H. Zhou et al., “The effect of Toll-like receptor 4 on β2-glycoprotein I-induced B cell activation in mouse model,” Molecular Immunology, vol. 71, pp. 78–86, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Nagai, K. P. Garrett, S. Ohta et al., “Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment,” Immunity, vol. 24, no. 6, pp. 801–812, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. E. A. Hayashi, A. Granato, L. S. Paiva, Á. L. Bertho, M. Bellio, and A. Nobrega, “TLR4 promotes B cell maturation: independence and cooperation with B lymphocyte-activating factor,” The Journal of Immunology, vol. 184, no. 9, pp. 4662–4672, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Wang, H. Zhou, H. Xie et al., “Epigallocatechin-3-gallate inhibits TF and TNF-α expression induced by the anti-β2GPI/β2GPI complex in human THP-1 cells,” International Journal of Molecular Medicine, vol. 33, no. 4, pp. 994–1002, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. S. A. Corfe and C. J. Paige, “The many roles of IL-7 in B cell development; mediator of survival, proliferation and differentiation,” Seminars in Immunology, vol. 24, no. 3, pp. 198–208, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. Q. Li, D. Han, W. Wang et al., “Toll-like receptor 4-mediated signaling regulates IL-7-driven proliferation and differentiation of B-cell precursors,” Cellular and Molecular Immunology, vol. 11, no. 2, pp. 132–140, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. C. J. Paige, P. W. Kincade, and P. Ralph, “Murine B cell leukemia line with inducible surface immunoglobulin expression,” The Journal of Immunology, vol. 121, no. 2, pp. 641–647, 1978. View at Google Scholar · View at Scopus
  47. E. A. Hayashi, S. Akira, and A. Nobrega, “Role of TLR in B cell development: signaling through TLR4 promotes B cell maturation and is inhibited by TLR2,” The Journal of Immunology, vol. 174, no. 11, pp. 6639–6647, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Booth, H. Wilson, S. Jimbo, and G. Mutwiri, “Modulation of B cell responses by Toll-like receptors,” Cell and Tissue Research, vol. 343, no. 1, pp. 131–140, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Medgyesi, E. Hobeika, R. Biesen et al., “The protein tyrosine phosphatase PTP1B is a negative regulator of CD40 and BAFF-R signaling and controls B cell autoimmunity,” Journal of Experimental Medicine, vol. 211, no. 3, pp. 427–440, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. Y. Mita, K. Dobashi, K. Endou et al., “Toll-like receptor 4 surface expression on human monocytes and B cells is modulated by IL-2 and IL-4,” Immunology Letters, vol. 81, no. 1, pp. 71–75, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. H. Shin, Y. Zhang, M. Jagannathan et al., “B cells from periodontal disease patients express surface Toll-like receptor 4,” Journal of Leukocyte Biology, vol. 85, no. 4, pp. 648–655, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. P. P. Sfikakis, J. N. Boletis, S. Lionaki et al., “Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial,” Arthritis & Rheumatism, vol. 52, no. 2, pp. 501–513, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. C. M. Buchta and G. A. Bishop, “Toll-like receptors and B cells: functions and mechanisms,” Immunologic Research, vol. 59, no. 1–3, pp. 12–22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. E. Boeglin, C. R. Smulski, S. Brun, S. Milosevic, P. Schneider, and S. Fournel, “Toll-like receptor agonists synergize with CD40L to induce either proliferation or plasma cell differentiation of mouse B cells,” PLoS ONE, vol. 6, no. 10, Article ID e25542, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Bolduc, E. Long, D. Stapler et al., “Constitutive CD40L expression on B cells prematurely terminates germinal center response and leads to augmented plasma cell production in T cell areas,” The Journal of Immunology, vol. 185, no. 1, pp. 220–230, 2010. View at Publisher · View at Google Scholar
  56. F. Loder, B. Mutschler, R. J. Ray et al., “B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals,” Journal of Experimental Medicine, vol. 190, no. 1, pp. 75–89, 1999. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Bornacelly, D. Mercado, N. Acevedo, and L. Caraballo, “The strength of the antibody response to the nematode Ascaris lumbricoides inversely correlates with levels of B-Cell Activating Factor (BAFF),” BMC Immunology, vol. 15, no. 1, article 22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. Y. Shen, F. You, C. Li et al., “Molecular cloning, bioinformatics analysis and functional characterization of B-cell activating factor in goat (Capra hircus),” Developmental and Comparative Immunology, vol. 36, no. 1, pp. 191–198, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Yan, M. Wu, Y. Yuan, Z. Z. Wang, H. Jiang, and T. Chen, “Priming of Toll-like receptor 4 pathway in mesenchymal stem cells increases expression of B cell activating factor,” Biochemical and Biophysical Research Communications, vol. 448, no. 2, pp. 212–217, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. K. Hoshino, O. Takeuchi, T. Kawai et al., “Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product,” Journal of Immunology, vol. 162, no. 7, pp. 3749–3752, 1999. View at Google Scholar
  61. A. M. Krieg, A.-K. Yi, S. Matson et al., “CpG motifs in bacterial DNA trigger direct B-cell activation,” Nature, vol. 374, no. 6522, pp. 546–549, 1995. View at Publisher · View at Google Scholar · View at Scopus
  62. R. P. Lisak and S. Ragheb, “The role of B cell-activating factor in autoimmune myasthenia gravis,” Annals of the New York Academy of Sciences, vol. 1274, no. 1, pp. 60–67, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. D. M. Allman, S. E. Ferguson, and M. P. Cancro, “Peripheral B cell maturation. I. Immature peripheral B cells in adults are heat-stable antigenhi and exhibit unique signaling characteristics,” The Journal of Immunology, vol. 149, no. 8, pp. 2533–2540, 1992. View at Google Scholar · View at Scopus
  64. A. Meyer-Bahlburg, S. F. Andrews, K. O. A. Yu, S. A. Porcelli, and D. J. Rawlings, “Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation,” The Journal of Experimental Medicine, vol. 205, no. 1, pp. 155–168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. D. Allman, R. C. Lindsley, W. DeMuth, K. Rudd, S. A. Shinton, and R. R. Hardy, “Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation,” Journal of Immunology, vol. 167, no. 12, pp. 6834–6840, 2001. View at Publisher · View at Google Scholar
  66. A. Patke, I. Mecklenbräuker, H. Erdjument-Bromage, P. Tempst, and A. Tarakhovsky, “BAFF controls B cell metabolic fitness through a PKCβ- and Akt-dependent mechanism,” The Journal of Experimental Medicine, vol. 203, no. 11, pp. 2551–2562, 2006. View at Publisher · View at Google Scholar · View at Scopus
  67. S. H. Smith and M. P. Cancro, “Cutting edge: B cell receptor signals regulate BLyS receptor levels in mature B cells and their immediate progenitors,” The Journal of Immunology, vol. 170, no. 12, pp. 5820–5823, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Batten, J. Groom, T. G. Cachero et al., “BAFF mediates survival of peripheral immature B lymphocytes,” Journal of Experimental Medicine, vol. 192, no. 10, pp. 1453–1465, 2000. View at Publisher · View at Google Scholar · View at Scopus
  69. B. Schiemann, J. L. Gommerman, K. Vora et al., “An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway,” Science, vol. 293, no. 5537, pp. 2111–2114, 2001. View at Publisher · View at Google Scholar · View at Scopus
  70. I. Debnath, K. M. Roundy, D. M. Dunn, R. B. Weiss, J. J. Weis, and J. H. Weis, “Defining a transcriptional fingerprint of murine splenic B-cell development,” Genes & Immunity, vol. 9, no. 8, pp. 706–720, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. W. N. Khan, “B cell receptor and BAFF receptor signaling regulation of B cell homeostasis,” Journal of Immunology, vol. 183, no. 6, pp. 3561–3567, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. J. Zhang, V. Roschke, K. P. Baker et al., “Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus,” The Journal of Immunology, vol. 166, no. 1, pp. 6–10, 2001. View at Publisher · View at Google Scholar · View at Scopus
  73. J. L. Reyes, A. Wang, M. R. Fernando et al., “Splenic B cells from hymenolepis diminuta-infected mice ameliorate colitis independent of T cells and via cooperation with macrophages,” The Journal of Immunology, vol. 194, no. 1, pp. 364–378, 2015. View at Publisher · View at Google Scholar · View at Scopus
  74. M. T. Caballero, M. E. Serra, P. L. Acosta et al., “TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization,” The Journal of Clinical Investigation, vol. 125, no. 2, pp. 571–582, 2015. View at Publisher · View at Google Scholar · View at Scopus
  75. Y. Tanaka, K. Saito, F. Shirakawa et al., “Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus,” The Journal of Immunology, vol. 141, no. 9, pp. 3043–3049, 1988. View at Google Scholar · View at Scopus
  76. A. Kitani, M. Hara, T. Hirose et al., “Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression,” Clinical and Experimental Immunology, vol. 88, no. 1, pp. 75–83, 1992. View at Google Scholar · View at Scopus
  77. A. Mizoguchi, E. Mizoguchi, R. N. Smith, F. I. Preffer, and A. K. Bhan, “Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice,” The Journal of Experimental Medicine, vol. 186, pp. 1749–1756, 1997. View at Google Scholar
  78. C. M. Hedrich, T. Rauen, S. A. Apostolidis et al., “Stat3 promotes IL-10 expression in lupus T cells through trans-activation and chromatin remodeling,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 37, pp. 13457–13462, 2014. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Mizoguchi and A. K. Bhan, “A case for regulatory B cells,” Journal of Immunology, vol. 176, no. 2, pp. 705–710, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. D. J. DiLillo, T. Matsushita, and T. F. Tedder, “B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer,” Annals of the New York Academy of Sciences, vol. 1183, pp. 38–57, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. L. E. P. M. Van Der Vlugt, S. Haeberlein, W. De Graaf, T. E. D. Martha, and H. H. Smits, “Toll-like receptor ligation for the induction of regulatory B cells,” Methods in Molecular Biology, vol. 1190, pp. 127–141, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. F. Flores-Borja, A. Bosma, D. Ng et al., “CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation,” Science Translational Medicine, vol. 5, no. 173, Article ID 173ra23, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. L. E. van der, L. A. Vlugt, A. Ozir-Fazalalikhan et al., “Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells,” PLoS ONE, vol. 7, Article ID e30883, 2012. View at Google Scholar
  84. L. E. P. M. van der Vlugt, E. Mlejnek, A. Ozir-Fazalalikhan et al., “CD24hiCD27+ B cells from patients with allergic asthma have impaired regulatory activity in response to lipopolysaccharide,” Clinical & Experimental Allergy, vol. 44, no. 4, pp. 517–528, 2014. View at Publisher · View at Google Scholar · View at Scopus
  85. D. F. Jelinek and J. K. Braaten, “Role of IL-12 in human B lymphocyte proliferation and differentiation,” Journal of Immunology, vol. 154, no. 4, pp. 1606–1613, 1995. View at Google Scholar · View at Scopus
  86. D. Durali, M.-G. de Goër de Herve, J. Giron-Michel, B. Azzarone, J.-F. Delfraissy, and Y. Taoufik, “In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment,” Blood, vol. 102, no. 12, pp. 4084–4089, 2003. View at Publisher · View at Google Scholar · View at Scopus
  87. N. V. Giltiay, C. P. Chappell, and E. A. Clark, “B-cell selection and the development of autoantibodies,” Arthritis Research & Therapy, vol. 14, supplement 4, article S1, 2012. View at Publisher · View at Google Scholar · View at Scopus
  88. S. Gözmen, T. H. Karapnar, Ö. Tüfekçi et al., “B-cell-activating factor, a proliferation inducing ligand and co-stimulatory molecules in the pathogenesis of immune thrombocytopenia in childhood,” Blood Coagulation & Fibrinolysis, vol. 27, no. 5, pp. 494–499, 2016. View at Publisher · View at Google Scholar · View at Scopus
  89. A. Boneparth and A. Davidson, “B-cell activating factor targeted therapy and lupus,” Arthritis Research and Therapy, vol. 14, supplement 4, p. S2, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. D. G. Arkfeld, “The potential utility of B cell-directed biologic therapy in autoimmune diseases,” Rheumatology International, vol. 28, no. 3, pp. 205–215, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. P. L. Meroni, C. B. Chighizola, F. Rovelli, and M. Gerosa, “Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers,” Arthritis Research & Therapy, vol. 16, no. 2, article 209, 2014. View at Publisher · View at Google Scholar · View at Scopus
  92. A. Al Marzooqi, A. Leone, J. Al Saleh, and M. Khamashta, “Current status and future prospects for the treatment of antiphospholipid syndrome,” Expert Review of Clinical Immunology, vol. 12, no. 9, pp. 927–935, 2016. View at Publisher · View at Google Scholar
  93. C. Lopez-Pedrera, M. A. Aguirre, P. Ruiz-Limon et al., “Immunotherapy in antiphospholipid syndrome,” International Immunopharmacology, vol. 27, no. 2, pp. 200–208, 2015. View at Publisher · View at Google Scholar · View at Scopus
  94. M. C. Glaum, S. Narula, D. Song et al., “Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production,” The Journal of Allergy and Clinical Immunology, vol. 123, no. 1, pp. 224–230.e4, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. S. Jain, S. B. Chodisetti, and J. N. Agrewala, “CD40 signaling synergizes with TLR-2 in the BCR independent activation of resting B cells,” PLoS ONE, vol. 6, no. 6, Article ID e20651, 2011. View at Publisher · View at Google Scholar · View at Scopus